Clinical Trial Update: Xeltis Hemodialysis Access Graft: aXess Pivotal Study [NA]

View source ↗

Summary

Xeltis reports an update on the aXess pivotal study evaluating the Xeltis Hemodialysis Access Graft for end-stage renal disease; the trial is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• aXess Hemodialysis Access Graft (aXess graft)

Snippet

Sponsor: Xeltis | Conditions: End-stage Renal Disease | NA | Status: ACTIVE_NOT_RECRUITING